FW: Consultant Sponsorship_ KENTS Annual Scientific Conference 2026
Mohammad Shahjahan (Head of Sales, SPL-Kenya)
Dear Anne,
Facilitate the following as per the allocation to the respective colleagues and account with Square Scientific Office account.
|
Market |
Amount |
Colleague Name |
|
Nairobi 1 |
77,500 |
Antony Wachira |
|
Nairobi 2 |
50,000 |
|
|
Nairobi 3 |
127,500 |
Irene Kerubo |
|
Nairobi 4 |
95,000 |
|
|
Nairobi 5 |
115,000 |
Simon Mawara |
|
Nairobi 6 |
57,500 |
Winfred Mbatha |
|
Nakuru |
65,000 |
Susan Nabwire |
|
Nyeri |
62,500 |
Anne Wanjiru |
|
Meru |
82,500 |
Rafayel Gikundi |
|
Eldoret |
90,000 |
George Pundo |
|
Kisumu |
145,000 |
Micheal Ichilla |
|
Kisii |
135,000 |
Kevin Wanyama |
|
Mombasa 1 |
80,000 |
Godfred Owour |
|
Mombasa 2 |
65,000 |
|
|
Total KES |
1,247,500 |
Colleagues: Please send the MPESA statement to Ms. Sarah after sending the money to the respective doctors as per the attached list.
Sarah: Please do the necessary checking after receiving the statement to confirm the money was sent to the specific persons as per the attached list. We may make calls to the respective numbers to confirm the same.
Thanks,
Shahjahan
From: Bulbul Islam (Sr. M-IMD-SPL) <bul...@squaregroup.com>
Sent: Monday, May 4, 2026 2:25 PM
To: Mohammad Shahjahan (Head of Sales, SPL-Kenya) <shahja...@squaregroup.com>
Cc: Rabbir Alam Razu Md.(IMD, SPL) <rab...@squaregroup.com>; Tajbiul Alam Bhuiyan Md. (IMD, SPL) <taj...@squaregroup.com>; Lutfor Rahman Mazumder H.M. (Head of Marketing, SPL-Kenya) <lutfor...@squaregroup.com>; Jabed Hossain ( CFO, SPL Kenya) <jabe...@squaregroup.com>;
Aminul Islam Md. (GM-IMD) <ami...@squaregroup.com>; 'kail...@madawa.co.ke' <kail...@madawa.co.ke>
Subject: RE: Consultant Sponsorship_ KENTS Annual Scientific Conference 2026
Approved.
From: Mohammad Shahjahan (Head of Sales, SPL-Kenya) <shahja...@squaregroup.com>
Sent: Monday, May 4, 2026 5:08 PM
To: Bulbul Islam (Sr. M-IMD-SPL) <bul...@squaregroup.com>
Cc: Rabbir Alam Razu Md.(IMD, SPL) <rab...@squaregroup.com>; Tajbiul
Alam Bhuiyan Md. (IMD, SPL) <taj...@squaregroup.com>; Lutfor Rahman
Mazumder H.M. (Head of Marketing, SPL-Kenya) <lutfor...@squaregroup.com>;
Jabed Hossain ( CFO, SPL Kenya) <jabe...@squaregroup.com>; Aminul
Islam Md. (GM-IMD) <ami...@squaregroup.com>; 'kail...@madawa.co.ke' <kail...@madawa.co.ke>
Subject: Consultant Sponsorship_ KENTS Annual Scientific Conference 2026
Dear Sir,
The Kenya Ear, Nose & Throat Society (KENTS) will be holding its Annual Scientific Conference from 14th to 17th May 2026 in Mombasa.
As you are aware, we have been actively working to expand our prescriber base and strengthen engagement with ENT consultants and clinicians across the country. We are encouraged by the growing support for our key products, particularly Flonaspray, Zimax, Loartin Fast, Tory, and Protas.
Flonaspray, being our flagship brand within the ENT segment, has shown significant progress. However, it continues to face strong competition, particularly from Flusort (Glenmark). In this context, maintaining and strengthening our relationships with key prescribers remains critical.
|
Sales Analysis |
2023 |
2024 |
2025 |
Commitment 2026 |
Gr. Over 2025 |
|||||
|
S/N |
Name of the Product |
Unit |
Value |
Unit |
Value |
Unit |
Value |
Unit |
Value |
|
|
1 |
Flonaspray |
40,556 |
24,982,496 |
45,668 |
28,131,488 |
57,844 |
35,820,624.18 |
78,089 |
48,103,070 |
34% |
Through continuous engagement and internal discussions, we have identified 111 ENT consultants and clinicians from across the country who have been consistent supporters of our brands. To acknowledge their contribution and further reinforce these relationships, we propose to support their participation in the conference by partially covering costs related to accommodation, registration, or transport.
|
Item |
ENT Surgeons to be sponsored |
Amount in KES |
Amount in USD |
|
KENTS conference 2026 |
111 |
1,247,500 |
9,596 |
This initiative is aimed at:
- Recognizing and appreciating their continued support
- Strengthening long-term professional relationships
- Driving increased prescription of our key brands, especially Flonaspray
In addition, we will be participating in the conference through an exhibition stall and other engagement activities, providing a valuable platform to showcase our products and interact directly with specialists.
We strongly believe that supporting their participation and partnering in this key professional event will enhance our brand presence, deepen engagement with the ENT community, and contribute to sustained business growth.
We kindly seek your approval for this initiative.
With sincere regards,
Mohammad Shahjahan